Molecular Matrix, Inc.


Molecular Matrix, Inc. is dedicated to advancing biotechnology through innovation, providing solutions in bone regeneration, tissue engineering, and regenerative medicine. They develop advanced biomaterials, including proteoglycan mimics like Osteo-P® BGS, to support bone healing and repair. The company emphasizes research, development, and the application of cutting-edge technologies such as smart biomaterials, 3D and 4D printing, nanotechnology, and personalized implants to improve patient outcomes.

Industries

3d-technology
biotechnology

Nr. of Employees

small (1-50)

Molecular Matrix, Inc.

Davis, California, United States, North America


Products

Hyper-crosslinked carbohydrate polymer bone graft substitute

A non-mineralized, synthetic porous bone void filler made from a hyper-crosslinked carbohydrate polymer that is biocompatible, biodegradable, and osteoconductive; designed to support bone ingrowth and be resorbed as healing occurs.


Services

Supply and distribution of synthetic bone graft substitutes

Manufacture and commercial supply of synthetic, non-mineralized biodegradable bone void fillers in multiple form factors for surgical use.

Research collaborations and preclinical study support

Collaborative R&D and participation in preclinical testing, technical presentations, and dissemination of study results at scientific meetings.

Expertise Areas

  • Bone graft substitute development
  • Biomaterials and scaffold engineering
  • Tissue engineering and regenerative medicine
  • Osteoimmunology and bone microenvironment research
  • Show More (4)

Key Technologies

  • Hyper-crosslinked carbohydrate polymer scaffolds
  • Porous scaffold architecture with controlled pore size
  • Biodegradable polymer biomaterials
  • Osteoconductive scaffold materials
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.